Related Experiment Video
Updated: Jul 27, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
[Rheumatic mitral aggression. Usefulness of 3d transesophageal echocardiography]
Kelly Cupe-Chacalcaje1, Lindsay Benites-Yshpilco1, Angela Cachicatari-Beltrán1
1. Hospital Nacional Guillermo Almenara, LimaPerú. Hospital Nacional Guillermo Almenara Lima Perú.
Insights
Rheumatic heart disease causes significant cardiovascular issues in young people globally. New 3D transesophageal echocardiography (TTE-3D) offers superior imaging for diagnosing mitral stenosis, improving upon traditional transthoracic echocardiography (TTE).
Area of Science:
- Cardiology
- Medical Imaging
- Pediatric Cardiovascular Disease
Context:
- Rheumatic heart disease (RHD) is a primary cause of pediatric cardiovascular disease, particularly in low-income nations.
- Mitral stenosis is a common and critical manifestation of rheumatic heart disease.
- Current diagnostic standards rely on transthoracic echocardiography (TTE), which has limitations in precise measurement and Doppler analysis.
Purpose:
- To evaluate the efficacy of transesophageal 3D echocardiography (TTE-3D) in diagnosing mitral stenosis in rheumatic heart disease.
- To compare the diagnostic capabilities of TTE-3D with conventional TTE.
- To assess the ability of TTE-3D to accurately delineate the severity and anatomical details of mitral stenosis.
Summary:
- Transesophageal 3D echocardiography (TTE-3D) provides realistic mitral valve visualization.
- TTE-3D accurately identifies the plane of maximum stenosis.
- This advanced imaging technique improves the assessment of commissural involvement in rheumatic mitral stenosis.
Impact:
- TTE-3D offers enhanced diagnostic accuracy for rheumatic heart disease, particularly mitral stenosis.
- Improved imaging may lead to more precise treatment strategies and better patient outcomes.
- This technology has the potential to refine diagnostic guidelines for RHD globally.
Abstract:
Rheumatic heart disease is the leading cause of cardiovascular disease in children under 25 years of age worldwide, with the highest prevalence in low-income countries. The usual and distinctive finding of rheumatic aggression is mitral stenosis, which leads to serious cardiovascular consequences. International guidelines establish transthoracic echocardiography (TTE) as the diagnostic test for rheumatic heart disease; however, it has limitations in the measurement of planimetry and those inherent to Doppler. Transesophageal 3D echocardiography (TTE-3D) is a new modality that shows realistic images of the mitral valve and has the added value of accurately locating the plane of maximum stenosis and better determining commissural involvement.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis III: Medical Management

